Madagascar summary indicators
| Baseline costing indicators | 2001 |
| GDP per capita1 | $243 |
| Population2 | $15,970,369 |
| Surviving infants2 | 611,000 |
| DTP-3 coverage3 | 55% |
| Total health expenditure per capita (Current $)4 | $5.8 |
| Total spending on routine immunization5 | $2,389,157 |
| - per DTP-3 immunized child | $7.1 |
| - per capita | $0.15 |
| - as a % of overall health expenditure | 2.6% |
| Total spending on the NIP (including campaigns)5 | $2,389,157 |
| - as a % of overall health expenditure | 2.6% |
| Future resource requirements, financing and gaps5 | 2003-2006 |
| Avg. annual resource requirements | $10,382,506 |
| - % new-underused vaccines | 23.0% |
| - per DTP-3 targeted child | $24.2 |
| Avg. annual secure funding | $7,701,335 |
| - % from government | 10.0% |
| - % from GAVI-Vaccine Fund | 50.8% |
| - % from other donors | 39.2% |
| Avg. annual probable funding | $724,154 |
| Avg. annual funding gap (secure and probable funding) | $1,957,017 |
| - % of resource requirements | 18.8% |
| - per DTP-3 targeted child | $4.6 |
Sources:
- World Development Indicators - World Bank for GDP
- United Nations Population Division, Department of Economic and Social Affairs, World Population Prospects the 2002 Revisions
- WHO-UNICEF Coverage Best Estimates
- WHO - World Health Report 2003
- Immunization Financing Database. Immunization specific spending is reported.